Rana Therapeutics Inc. made a bold move by acquiring the messenger RNA (mRNA) replacement therapy (MRT) platform developed by units of Shire plc, which took an undisclosed equity stake in Rana and is set to receive undisclosed milestones and royalties on products developed with the technology.